American Portfolios Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $193K | Sell |
665
-114
| -15% | -$33K | 0.01% | 1028 |
|
|
2022
Q2 | $220K | Sell |
779
-155
| -17% | -$43.7K | 0.01% | 1009 |
|
|
2022
Q1 | $244K | Sell |
934
-225
| -19% | -$58.7K | 0.01% | 1068 |
|
|
2021
Q4 | $255K | Sell |
1,159
-77
| -6% | -$16.9K | 0.01% | 1029 |
|
|
2021
Q3 | $224K | Sell |
1,236
-2,152
| -64% | -$390K | 0.01% | 1062 |
|
|
2021
Q2 | $683K | Buy |
3,388
+97
| +3% | +$19.6K | 0.03% | 592 |
|
|
2021
Q1 | $707K | Buy |
3,291
+146
| +5% | +$31.4K | 0.03% | 530 |
|
|
2020
Q4 | $743K | Buy |
3,145
+134
| +4% | +$31.7K | 0.04% | 431 |
|
|
2020
Q3 | $819K | Sell |
3,011
-3,478
| -54% | -$946K | 0.05% | 344 |
|
|
2020
Q2 | $1.88M | Buy |
6,489
+2,311
| +55% | +$671K | 0.12% | 166 |
|
|
2020
Q1 | $994K | Buy |
4,178
+788
| +23% | +$188K | 0.08% | 221 |
|
|
2019
Q4 | $742K | Buy |
3,390
+251
| +8% | +$55K | 0.05% | 328 |
|
|
2019
Q3 | $532K | Buy |
3,139
+158
| +5% | +$26.8K | 0.04% | 378 |
|
|
2019
Q2 | $547K | Buy |
2,981
+2,391
| +405% | +$438K | 0.05% | 365 |
|
|
2019
Q1 | $109K | Buy |
590
+216
| +58% | +$39.7K | 0.01% | 854 |
|
|
2018
Q4 | $62K | Buy |
374
+66
| +21% | +$10.9K | 0.01% | 930 |
|
|
2018
Q3 | $59.4K | Buy |
308
+1
| +0.3% | +$193 | 0.01% | 1025 |
|
|
2018
Q2 | $52.2K | Buy |
307
+146
| +91% | +$24.8K | 0.01% | 1051 |
|
|
2018
Q1 | $26.2K | Buy |
+161
| New | +$26.2K | ﹤0.01% | 1290 |
|